TMDI - Titan Medical to lay off staff as asset sale takes priority
- Canada-based Titan Medical ( NASDAQ: TMDI ) announced plans to lay off as many as 49 employees on Wednesday as the MedTech company prioritizes the sale of assets amid an ongoing strategic review.
- The company said that the board had prioritized the sale of all or a part of its assets as its previously disclosed review for strategic alternatives has failed to draw the buyout interest,
- That includes Titan’s ( TMDI ) intellectual property portfolio of more than 235 patents and patent applications.
- The management will also implement immediate cost-cutting initiatives, including the removal of 48 employees at the company’s Chapel Hill operations. The layoffs will include those who were temporarily furloughed in December.
- The company will retain 18 staff to focus on ongoing operations, including potential strategic transactions and maintaining its IP portfolio.
- Citing the ongoing strategic review process, Titan ( TMDI ) does not rule out further cost-cutting measures.
- The company shares have plunged over the past six months leading to a Nasdaq notice in December on failure to meet the minimum bid price requirement.
For further details see:
Titan Medical to lay off staff as asset sale takes priority